Guilhem Richard

Guilhem Richard is a partner in Goodwin’s Life Sciences and Technology groups.

He specializes in capital markets and corporate finance particularly in the biotech, medtech and tech sectors. His experience includes a wide range of capital market transactions on Euronext and Nasdaq from equity (IPOs, dual listings, capital increases, private placements, block sales and ATM offerings…) to debt (high yield, OCEANE, ORA).

Guilhem also assists listed companies and their boards with their financing strategies and day-to-day issues relating to corporate and securities law and corporate governance.

Prior to joining Goodwin, Guilhem was a partner at Gide and previously worked in other international law firms.

Master, University of Paris I – Panthéon-Sorbonne (Business Law); Master, Université Catholique de Louvain (Economic Law); Master, ESCP Business School (Management)